A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants
Clinical trial NCT02908685 · COMPLETED
Trial details
- NCT number
- NCT02908685
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-19
- Primary completion
- 2019-09-06
- Enrollment
- 231
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.